GEODE CAPITAL MANAGEMENT, LLC
Position in NAUT — Nautilus Biotechnology, Inc.
CIK 1214717
BOSTON, MA
Position in NAUT
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,366,549
+$24,877 QoQ
Shares Held
1,265,535
+109.7% QoQ
Ownership
0.996%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 93 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NAUT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,426,307 across 521 Biotechnology names. NAUT ranks #287 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in NAUT
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,366,549 | 1,265,535 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $2,341,672 | 603,524 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,093,772 | 560,909 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $467,793 | 553,602 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $401,361 | 553,602 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $991,029 | 1,151,022 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,919,469 | 1,142,542 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $3,236,294 | 1,135,542 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $2,655,270 | 1,134,731 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $3,254,435 | 1,106,951 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $3,185,109 | 1,065,254 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $3,206,031 | 1,014,567 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,895,023 | 1,006,466 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,752,510 | 993,686 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,729,562 | 960,868 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,024,746 | 955,069 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,557,595 | 950,779 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,284,168 | 526,306 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,565,125 | 495,198 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $2,369,247 | 385,871 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $660,509 | 65,397 | Shares | Defined | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||